Gadoteridol
CAS No. 120066-54-8
Gadoteridol( SQ-32692 | Gd-HP-DO3A | ProHance )
Catalog No. M27077 CAS No. 120066-54-8
Gadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 48 | Get Quote |
|
| 50MG | 65 | Get Quote |
|
| 100MG | 95 | Get Quote |
|
| 200MG | 140 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGadoteridol
-
NoteResearch use only, not for human use.
-
Brief DescriptionGadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.
-
DescriptionGadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.
-
In Vitro——
-
In VivoGadoteridol (1 mM; intracerebral injection; once) enhances distribution of rAAV1 in the rat hippocampus. Animal Model:Sprague-Dawley rats (3 -5 months) Dosage:1 mM/rat Administration:Intracerebral injection, once, co-infused with rAAV1 or AAV5Result:Increased the transduction efficiency of AAV1 but not AAV5.
-
SynonymsSQ-32692 | Gd-HP-DO3A | ProHance
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number120066-54-8
-
Formula Weight557.68
-
Molecular FormulaC17H28GdN4O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 280 mg/mL (502.08 mM))
-
SMILES[Gd+3]1234567[N]8(CC[N]1(CC[N]2(CC[N]3(CC8)CC([O-]4)=O)CC([O-]5)=O)CC([O-]6)=O)CC(C)O7
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Cyclic MKEY
MKEY, a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, has been shown to protect against atherosclerosis and aortic aneurysm formation by mediating inflammation, but whether it modulates neuroinflammation and brain injury has not been studied.
-
BMS-502
BMS-502 is a potent dual inhibitor of diacylglycerol kinase (DGK) α and ζ that induces immune responses in human and mouse T cells and blocks intracellular checkpoint signaling in T cells.
-
Prolactin Releasing ...
Prolactin Releasing Peptide (1-31), human is a high affinity GPR10 ligand that cause the release of the prolactin. Human and rat Prolactin Releasing Peptide (1-31) binds to GPR10 with Kis of 1.03 and 0.33 nM, respectively.Prolactin-releasing peptide is a specific prolactin releasing peptide.
Cart
sales@molnova.com